Along with the activation of JNK signalling in tumour without CDK6 amplification with combination therapy, the absence of ERK signal further reflects the transition to an endocrine independent resistance state, with reduced reliance on the interaction of ESR1/ERK [Figure 2]. Here, ESR1 is linked to neoplasm.